Chemotherapy-induced hypersensitivity reaction

American Journal of Nursing

Volumn 100, Issue 4, 2000, Pages 53-54

  Meyers, Jamie S ^a   Kearney, Kathleen ^b  

^a Research Medical Center Brookside Campus   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTINEOPLASTIC AGENT; DIPHENHYDRAMINE; METHYLPREDNISOLONE; PACLITAXEL;

ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; EMERGENCY; FEMALE; HUMAN; MIDDLE AGED; OVARY TUMOR;

ANTI-ALLERGIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIPHENHYDRAMINE; DRUG HYPERSENSITIVITY; EMERGENCIES; FEMALE; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 0034169063     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.2307/3522027     Document Type: Article

References (5)

1. Labovich TM. Acute hypersensitivity reactions to chemotherapy. Semin Oncol Nurs 1999;15(3):222-31.
2. Weiss R, B. Miscellaneous toxicities. In: DeVita VT, et al., editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 2796-806
3. Rowinsky EK, Donehower RC. Paclitaxel (Taxol) [published erratum appears in N Engl J Med 1995 Jul 6;333(1):75]. N Engl J Med 1995;332(15):1004-14.
4. Olson JK, et al. Taxol hypersensitivity: rapid retreatment is safe and cost effective. Gynecol Oncol 1998;68(1):25-8.
5. Peereboom DM, et al. Successful re-treatment with Taxol after major hypersensitivity reactions. J Clin Oncol 1993;11(5):885-90.